lovastatin has been researched along with Adenocarcinoma, Follicular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engel, E; Fröhlich, E; Wahl, R | 1 |
1 other study(ies) available for lovastatin and Adenocarcinoma, Follicular
Article | Year |
---|---|
Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Dipeptidyl Peptidase 4; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lovastatin; Thyroid Neoplasms; Vitamin A | 2011 |